#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Myelin oligodendrocyte glycoprotein antibody-associated disease Systemic candida Pancreatic carcinoma Myotonic dystrophy Malignant peritoneal neoplasm Ventricular fibrillation VEXAS syndrome Marfan's syndrome Idiopathic intracranial hypertension Microscopic polyangiitis Angiosarcoma recurrent Necrotising myositis Anaemia Liposarcoma metastatic Pulmonary tuberculosis More trials…

    Learn about Rare Diseases

    Hepatic angiosarcoma – Basic Information Mastocytosis Vascular malformation – Basic Information Chondrosarcoma – Diagnostics Osteosarcoma – Diagnostics CADASIL – Trials in Disease Proteus syndrome – Trials in Disease Breast angiosarcoma Behcet’s syndrome – Diagnostics Hereditary neuropathic amyloidosis – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    CILOSTAZOL Carfilzomib Immunoglobulin M Mirabegron Gallium (68Ga) Gozetotide Topotecan Isoflurane Tasipimidine Odm-208 A/H1N1 INFLUENZA VACCINE Tisagenlecleucel Ciclesonide Exenatide Rozanolixizumab Fenebrutinib Toldc Dazucorilant Caffeine Insulin Human (Rdna) Batoclimab More therapies…

    Learn about Your Condition

    Pancreaticoduodenectomy Undifferentiated sarcoma Biliary neoplasm Psychological trauma Ovarian cancer stage IV Coronary artery disease Synovial sarcoma metastatic Kearns-Sayre syndrome Seizure Gout Myotonia Haemorrhage Sinus rhythm Glomerulonephritis membranous Malignant glioma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Eye Diseases

  • Study on Ketotifen Eye Drops for Treating Seasonal Allergic Conjunctivitis in Patients

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Conjunctivitis allergic
    Investigated Drugs:
    • Ketotifen Hydrogen Fumarate
    Italy

  • Study on the Safety and Effectiveness of RGN-259 Eye Drops for Patients with Neurotrophic Keratopathy

    Not recruiting

    3 1
    Investigated Diseases:
    • Neurotrophic keratopathy
    Investigated Drugs:
    • Timbetasin Acetate
    Germany Italy Poland Spain

  • Study on the Effect and Safety of Phenylephrine Hydrochloride, Tropicamide, and Lidocaine Hydrochloride in Children with Cataracts Undergoing Surgery

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Cataract
    Investigated Drugs:
    • Phenylephrine Hydrochloride
    • Tropicamide
    • Lidocaine Hydrochloride
    Belgium

  • Study on JNJ-81201887 for Treating Geographic Atrophy in Age-related Macular Degeneration Patients

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Dry age-related macular degeneration
    Investigated Drugs:
    • Adeno-Associated Virus Serotype 2 Encoding Soluble Cd59
    • Prednisone
    • Triamcinolone Acetonide
    Belgium Czechia Denmark Germany Hungary Italy +5

  • Study on Linsitinib for Patients with Active, Moderate to Severe Thyroid Eye Disease

    Not recruiting

    2 1
    Investigated Diseases:
    • Endocrine ophthalmopathy
    Investigated Drugs:
    • Linsitinib
    Italy Spain

  • Study on the Safety and Effectiveness of Ripasudil Eye Drops for Patients with Fuchs Dystrophy After Cataract Surgery

    Not recruiting

    3 1
    Investigated Diseases:
    • Corneal dystrophy
    Investigated Drugs:
    • Ripasudil
    Denmark Germany Spain
Previous Page
1 … 32 33 34 35 36 37
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!